Overall Goals and Objectives:
1. To understand testing strategies for rare genetic diseases.
2. To understand the pathogenesis of lung and liver diseases in Alpha-1 Antitrypsin deficiency.
3. To understand the impact of rare disease communities in the health care system.
Recommended CitationStrange, Charlie, "Rare Diseases: The Case of Alpha-1 Antitrypsin Deficiency" (2011). Division of Pulmonary and Critical Care Medicine Presentations and Grand Rounds. Presentation 27.